Commons Sense

House of Commons · General Debate

Brain Tumours

18 October 2023 · 1 other contributor

Opened by Siobhain McDonagh Lab Mitcham and Morden

NHS

Summarised by AI from the official record, so it can contain mistakes.

Read the full transcript on Parliament.uk

At a glance

Siobhain McDonagh raised concerns about brain tumours in the House of Commons. Other MPs contributed to the debate.

Key points

  • Ms McDonagh moved a bill to set targets for clinical trials on glioblastoma and require training for medical oncologists in brain cancers.
  • Ms McDonagh highlighted the current low survival rates and lack of progress in treating brain tumours.
  • Ms McDonagh expressed hope for potential cures within 10 years with new measures in place.

How the debate unfolded

MPs spoke in turn to share their views and ask questions. Here's what each person said.

Opened the debate

Siobhain McDonagh Lab Mitcham and Morden

Ms McDonagh moved a bill to set targets for clinical trials on glioblastoma, require training for medical oncologists in brain cancers, mandate the trialling of tumour drugs on brain tumours, provide requirements for neuro-oncology multidisciplinary teams and drug availability for clinical trials. She emphasised the current bleak landscape with low survival rates and lack of progress, yet expressed hope after discussions with experts, citing a potential cure within 10 years if new measures are taken.

Other contributors (1)
  • Eleanor Laing Con not specified constituency

    Expressed sympathy for the mover and confirmed that there will be no opposition to the bill.

Get updates like this by email
▸ Assessment & feedback
Summary accuracy